Post-Vax Clot Case Supports Angiomax Use

(MedPage Today) -- Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.
The 40-year-old woman presented with a headache on the same day that the...